Authors: Neilan, CL Nguyen, TMD Schiller, PW Pasternak, GW

Citation: Cl. Neilan et al., Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, ahighly potent and selective mu-opioid peptide, EUR J PHARM, 419(1), 2001, pp. 15-23

Authors: Neilan, CL Kenyon, E Kovach, MA Bowden, K Claycomb, WC Traynor, JR Bolling, SF

Citation: Cl. Neilan et al., An immortalized myocyte cell line, HL-1, expresses a functional delta-opioid receptor, J MOL CEL C, 32(12), 2000, pp. 2187-2193

Authors: Derrick, I Neilan, CL Andes, J Husbands, SM Woods, JH Traynor, JR Lewis, JW

Citation: I. Derrick et al., 3-deoxyclocinnamox: The first high-affinity, nonpeptide mu-opioid antagonist lacking a phenolic hydroxyl group, J MED CHEM, 43(17), 2000, pp. 3348-3350

Authors: Neilan, CL Akil, H Woods, JH Traynor, JR

Citation: Cl. Neilan et al., Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists, BR J PHARM, 128(3), 1999, pp. 556-562